Search results for "Patient Rights"

Haeundae Paik Hospital Ranks No. 2 Nationwide in National Patient Experience Assessment

Haeundae Paik Hospital Ranks No. 2 Nationwide in National Patient Experience Assessment

Inje University Haeundae Paik Hospital has posted the second-highest overall score nationwide in a major patient-evaluated review of hospital care.
A Medicine Not Yet Named: The ‘27th Karte’ We Will Write

A Medicine Not Yet Named: The ‘27th Karte’ We Will Write

Not long ago, I binge-watched a Japanese medical drama titled The 19th Karte.What is a "karte"? A quick search reveals it stems from the German word...
Seoul’s Major Hospitals Split in Patient Experience Survey as HIRA Discloses First-Ever Letter Grades

Seoul’s Major Hospitals Split in Patient Experience Survey as HIRA Discloses First-Ever Letter Grades

Asan Medical Center and Samsung Medical Center earned Grade 1 ratings in the latest national patient experience survey,...
Keimyung University Dongsan Hospital Ranks No. 1 Nationwide in Patient Experience for Second Consecutive Time

Keimyung University Dongsan Hospital Ranks No. 1 Nationwide in Patient Experience for Second Consecutive Time

"Which hospital do you go to if you want to be treated like a human being?"For patients and caregivers heading to the...
Daegu Champions Industry and Research Base in Bid for National Dental Research Institute

Daegu Champions Industry and Research Base in Bid for National Dental Research Institute

One of the most prominent issues facing Daegu Metropolitan City’s dental community is the campaign to attract the...
Daewoong Pharmaceutical Cuts Off Hospital Sales After Domestic Nabota Vials Surface in the U.S.

Daewoong Pharmaceutical Cuts Off Hospital Sales After Domestic Nabota Vials Surface in the U.S.

Daewoong Pharmaceutical announced on July 23 that it has severed supply transactions with a domestic medical...
HK inno.N’s Obesity Drug Candidate Outperforms Wegovy in Head-to-Head Phase 2 Trial

HK inno.N’s Obesity Drug Candidate Outperforms Wegovy in Head-to-Head Phase 2 Trial

HK inno.N announced on June 9 that its obesity drug candidate, ecnoglutide, demonstrated superior weight-loss efficacy...
Hanmi Pharm Revives 'LAPSCOVERY' Momentum with $1.26B Eli Lilly Licensing Deal

Hanmi Pharm Revives 'LAPSCOVERY' Momentum with $1.26B Eli Lilly Licensing Deal

Hanmi Pharmaceutical has licensed its novel drug candidate sonefpeglutide to global pharmaceutical giant Eli Lilly and...
Samsung Bioepis Set to Launch Eylea Biosimilar in the U.S. Next January

Samsung Bioepis Set to Launch Eylea Biosimilar in the U.S. Next January

Samsung Bioepis announced on the 12th that it has entered into a patent license agreement with the original developer...